welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
George Dickson, PhD
Professor of Molecular Cell Biology
Centre for Biomedical Sciences
Royal Holloway - University of London
Surrey, United Kingdom
George Dickson is Professor of Molecular Cell Biology at Royal Holloway, University of London (RHUL). He has spent most of his career studying neuromuscular disease and muscle cell biology, including the first cloning of an intact dystrophin gene, the discovery of the role of cell adhesion molecules in muscle stem cell fusion, the first identification of utrophin, and the first description of exon skipping in Duchenne muscular dystrophy (DMD). He is a member of various consortiums and projects of gene therapy. He is a past President of the European Society of Gene & Cell Therapy, and a past Secretary and founder member of the British Society for Gene Therapy.
His present research includes optimisation of exon-skipping and antisense oligonucleotide formulations for DMD, inhibition of myostatin by RNA skipping and gene therapy for DMD, development of dystrophin minigenes and AAV viral vectors for treatment of DMD, direct genome correction of DMD using endonuclease-mediated genome surgery and general muscle fibre and stem cell biology.
Sarepta shoots higher as sales of $300,000-a-year drug exceed expectationsSarepta announced second-quarter revenue...
Clinical trial of gene therapy for Duchenne muscular dystrophy underway at University of Florida HealthScreening has resumed in a clinical tria...
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophyDuchenne muscular dystrophy (DMD) is a l...
Kristin Engelstad, MS, CGCKristin Engelstad is a clinical study co...
The emerging role of viral vectors as vehicles for DMD gene editingDuchenne muscular dystrophy (DMD) is a g...
Personalized gene and cell therapy for Duchenne Muscular DystrophyDystrophinopathies are diseases caused b...
Sarepta Therapeutics Announces that Phase 1/2a Duchenne Muscular Dystrophy (DMD) Micro-Dystrophin Gene Therapy Trial...Sarepta Therapeutics, Inc., a commercia...